An Open-label Study to Evaluate the Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).
Phase of Trial: Phase II/III
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Ecopipam (Primary)
- Indications Stuttering
- Focus Therapeutic Use
- 24 Oct 2016 Status changed from not yet recruiting to recruiting.
- 29 Sep 2016 New trial record